A
$ Value
—
Shares
38,182
Price
—
Filed
May 13
Insider
Name
Metzinger Joseph Anthony
Title
VP, Chief Accounting Officer
CIK
0002067729
Roles
Officer
Transaction Details
Transaction Date
2025-05-12
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
38,182
Footnotes
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of May 12, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. | Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of May 12, 2025.
Filing Info
Metzinger Joseph Anthony's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | DVAX | U | — |
| 2026-02-10 | DVAX | D | — |
| 2026-02-10 | DVAX | D | — |
| 2025-12-24 | DVAX | F | $86K |
| 2025-12-23 | DVAX | M | — |
| 2025-12-23 | DVAX | M | — |
| 2025-05-12 | DVAX | A | — |
| 2025-05-12 | DVAX | A | — |
Other Insiders at DVAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| KISNER DANIEL L | — | — | 2026-02-10 |
| SILVERNAIL LAUREN P | — | — | 2026-02-10 |
| CANO FRANCIS | — | — | 2026-02-10 |
| Myers Scott Dunseth | — | — | 2026-02-10 |
|
Slebir John L
SVP General Counsel
|
— | — | 2026-02-10 |
|
Novack David F
President & COO
|
— | — | 2026-02-10 |
|
Spencer Ryan
CEO and Director
|
— | — | 2026-02-10 |
|
MacDonald Kelly
SVP and CFO
|
— | — | 2026-02-10 |
| Sun Elaine D | — | — | 2026-02-10 |
| MacGregor Brent | — | — | 2026-02-10 |
| Deep Track Biotechnology Master Fund, Ltd. | — | — | 2026-02-10 |
| Emini Emilio | — | — | 2026-02-10 |
|
Metzinger Joseph Anthony
VP, Chief Accounting Officer
|
— | — | 2026-02-10 |